Scholarlink

Purpose of Review <p>Although <i>SCN5A</i> variants are an established cause of arrhythmia and conduction disease, their association with dilated cardiomyopathy (DCM) is less studied. This review summarizes recent insights into <i>SCN5A</i>-related cardiomyopathy, focusing on genotype-phenotype correlations, overlap with arrhythmia, and implications for management.</p> Recent Findings <p>Both gain- and loss-of-function <i>SCN5A</i> variants are associated with cardiomyopathy, found in 0.5–0.9% of DCM cases. Presentation ranges from isolated DCM to overlap phenotypes, in both pediatric and adult patients. High variability and intrafamilial heterogeneity suggest pleiotropic effects and variable penetrance. High prevalence of arrhythmias and conduction disease suggests the DCM phenotype may be mediated by electrical disturbances. However, functional studies and cases without prior arrhythmia suggest <i>SCN5A</i> variants may directly contribute to structural myocardial changes.</p> Summary <p><i>SCN5A</i>-related cardiomyopathy is a rare disorder at the intersection of structural and electrical heart disease. Genotype-informed strategies, including arrhythmia management, and early cascade genetic screening are clinically relevant. Further research should address <i>SCN5A</i>-specific risk management in DCM patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

SCN5A Cardiomyopathy: from Ion Channel Dysfunction To Clinical Disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月9日

查看全文
  • Astrid B.M. Heymans,
  • Lorenzo Bianchi,
  • Paul G.A. Volders,
  • Saskia N. van der Crabben,
  • Job A.J. Verdonschot

摘要

Purpose of Review

Although SCN5A variants are an established cause of arrhythmia and conduction disease, their association with dilated cardiomyopathy (DCM) is less studied. This review summarizes recent insights into SCN5A-related cardiomyopathy, focusing on genotype-phenotype correlations, overlap with arrhythmia, and implications for management.

Recent Findings

Both gain- and loss-of-function SCN5A variants are associated with cardiomyopathy, found in 0.5–0.9% of DCM cases. Presentation ranges from isolated DCM to overlap phenotypes, in both pediatric and adult patients. High variability and intrafamilial heterogeneity suggest pleiotropic effects and variable penetrance. High prevalence of arrhythmias and conduction disease suggests the DCM phenotype may be mediated by electrical disturbances. However, functional studies and cases without prior arrhythmia suggest SCN5A variants may directly contribute to structural myocardial changes.

Summary

SCN5A-related cardiomyopathy is a rare disorder at the intersection of structural and electrical heart disease. Genotype-informed strategies, including arrhythmia management, and early cascade genetic screening are clinically relevant. Further research should address SCN5A-specific risk management in DCM patients.